Enzon Pharmaceuticals Inc (ENZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 0 | 26 | 701 | 52 | 207 |
| Gross Profit | N/A | 26 | 701 | 52 | 207 |
| Operating Expenses | 1,044 | 1,058 | 1,170 | 1,357 | 1,180 |
| Operating Income | -1,044 | -1,032 | -469 | -1,305 | -973 |
| Other Income | 2,261 | 646 | 7 | 1 | 0 |
| Pre-tax Income | 1,217 | -386 | -462 | -1,304 | -973 |
| Income Tax | -156 | -200 | 7 | 7 | 6 |
| Net Income Continuous | 1,373 | -186 | -469 | -1,311 | -979 |
| Net Income | $1,373 | $-186 | $-469 | $-1,311 | $-979 |
| EPS Basic Total Ops | 0.00 | -0.02 | -0.03 | -0.03 | -0.02 |
| EPS Basic Continuous Ops | 0.02 | 0.00 | -0.01 | -0.03 | -0.02 |
| EPS Diluted Total Ops | 0.00 | -0.02 | -0.03 | -0.03 | -0.02 |
| EPS Diluted Continuous Ops | 0.02 | 0.00 | -0.01 | -0.03 | -0.02 |
| EPS Diluted Before Non-Recurring Items | 0.00 | -0.02 | -0.03 | -0.03 | -0.02 |
| EBITDA(a) | $-1,044 | $-1,032 | $-469 | $-1,305 | $-973 |